Home Forums Main Forum Media & News FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hep B

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #23542
    Tommy
    • Guardian Angel
    • ★★★★★
    @tommy

    FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hepatitis B Reactivation Risk

    http://www.raps.org/Regulatory-Focus/News/2016/10/04/25946/FDA-Adds-Boxed-Warning-to-Hepatitis-C-Drugs-Warns-of-Hepatitis-B-Reactivation-Risk/

    So if one had Hepatitis B would you still treat? I’d take that chance since a very small number of cases were reported. By the way, that warning was from the Food and Drug Administration which is USA based.

    I just got my prescription from Dr Freeman and I plan on getting my meds. Never had hep B anyway. Just information here.


    Genotype 1A
    ALT 473
    AST 226
    Virus Load 3,119,030
    Results as of May-2016
    5 week viral load/undetected as of 12/02/2016
    Liver Biopsy Results from Feb 2013
    Portal/Periportal chronic inflammation and mild interface hepatitis (Grade 2)
    Focal Lobular chronic inflammation (Grade 1)
    Portal/Periportal fibrosis (stage 1-2 trichrome and reticulin stains utilized)
    Negative Iron stains.

    #23630
    Avatar photobeaches
    • Guardian Angel
    • ★★★★★
    @beaches

    Hi Tommy
    This is a bit of a storm ina teacup. There’s another post on the forum bout this where Dr James addresses it.
    I have had Hep B and it worried me a bit but now I’m happy again


    Genotype 1a
    Diagnosed in 2004, had HCV for all my adult life. Until 2016!!!!
    Harvoni treatment, started 19 March 2016
    4 week results Bilirubin 12 down from 14 pre treatment,
    Gamma 25 down from 52, ALT 19 down from 63, AST 19 down from 47,
    VL <15 down from a lazy 6 million or so

    EOT Results
    Bilirubin 10, GGT 18, ALT 19, AST 21, VL UND

    12 Weeks post EOT
    Bilirubin 11, GGT 16, ALT 22, AST 20, VL UND
    Cured baby

Viewing 2 posts - 1 through 2 (of 2 total)
  • You must be logged in to reply to this topic.